scholarly journals Chemosensing Test Paper Based on Aggregated Nanoparticles of a Barbituric Acid Derivative

2020 ◽  
Vol 2020 ◽  
pp. 1-9
Author(s):  
Jinzhen Xu ◽  
Hanjun Zhang ◽  
Zhen Xu ◽  
Furong Tao ◽  
Yuezhi Cui ◽  
...  

The development of sensitive, cheap, and portable methods for detecting nitroaromatics explosives has a profound significance and value for public health and environmental protection. For this purpose, a new D-π-A barbituric acid derivative CB-CYH with aggregation-induced emission (AIE) behavior was synthesized, which can interact with picric acid through photoinduced electron transfer (PET). Scanning electron microscopy (SEM) and dynamic light scattering (DLS) indicate that the enhanced emission of the compounds is related to the formation of nano-aggregates. It is well known that an important source of mechanochromic fluorescence (MCF) characteristic materials is the compound with AIE characteristics. The chemosensing test paper prepared by aggregated nanoparticles based on AIE properties is often subjected to external friction or squeeze during transportation or storage, resulting in changes of their optical properties, and destruction of test paper followed. Therefore, the development of compounds with AIE properties and stable optical properties in the presence of external stimuli is particularly important for chemosensing test paper. Molecular dynamics simulation (MDS) shows that the presence of hydrophobic cycloalkyl group in CB-CYH, which caused the molecules to be closely interspersed with each other; hence, it is difficult to change the microstructure and stacking mode of molecules by external stimulation simultaneously; the optical properties are not changed by external stimuli. Therefore, the test paper based on the AIE effect of CB-CYH was developed as chemosensing test paper for the detection of nitroaromatics.

1984 ◽  
Vol 49 (17) ◽  
pp. 3227-3230 ◽  
Author(s):  
Wayne J. Brouillette ◽  
Joyce D. Friedrich ◽  
Donald D. Muccio

2005 ◽  
Vol 13 (3) ◽  
pp. 193-202
Author(s):  
Jun‐Ping Zhang ◽  
Nai‐Xing Wang ◽  
Yun‐Xu Yang ◽  
An‐Guang Yu ◽  
Wu‐Wei Wang ◽  
...  

2019 ◽  
Vol 11 (43) ◽  
pp. 5553-5561 ◽  
Author(s):  
Qiqi Zou ◽  
Furong Tao ◽  
Zhen Xu ◽  
Yunqiao Ding ◽  
Yan Tian ◽  
...  

A new dibenzothiophene-based barbituric acid derivative (DTB) with an aggregation induced emission (AIE) effect was synthesized as a naked-eye colorimetric and fluorescent probe for CN−.


Molecules ◽  
2020 ◽  
Vol 25 (12) ◽  
pp. 2856
Author(s):  
Yi-Jen Liao ◽  
Shih-Ming Hsu ◽  
Chia-Ying Chien ◽  
Yuan-Hsi Wang ◽  
Ming-Hua Hsu ◽  
...  

Hepatocellular carcinoma (HCC) is a common cause of cancer death worldwide. Sorafenib, a multikinase inhibitor, is the first-line drug approved by the Food and Drug Administration (FDA) for the treatment of patients with advanced HCC. However, most patients who continuously receive sorafenib may acquire resistance to this drug. Therefore, it is important to develop a new compound to treat liver cancer and sorafenib-resistant liver cancer. Barbituric acid derivatives have been used as antiasthmatic drugs in the clinic. We previously reported that a novel barbituric acid derivative inhibited carbon tetrachloride-induced liver fibrosis in mice, but its effects on liver cancer remain unknown. Thus, the purpose of this study was to investigate the antitumor effect of barbituric acid derivatives on HCC cells and sorafenib-resistant HCC cells (HCC-SRs). Our findings reveal that one of the barbituric acid derivatives, BA-5, significantly inhibited HCC and HCC-SR cell viability in a dose- and time-dependent manner. Therefore, compound BA-5 was selected for further experiments. Western blot data revealed that BA-5 treatment decreased the phosphorylation of AKT/p70s6k without affecting the MAPK pathway and increased cleaved PARP and cleaved caspase-7 in both HCC and HCC-SR cells. Since epithelial-mesenchymal transition plays a significant role in regulating cancer invasion and migration, we used the wound healing assay to evaluate the antimigratory effect of compound BA-5. The results showed that BA-5 treatment inhibited HCC and HCC-SR cell migration and reduced Vimentin protein expression. These results were confirmed by microarray analysis showing that BA-5 treatment influenced cancer cell motility and growth-related pathways. In the xenograft mouse model experiment, BA-5 administration significantly inhibited HCC cancer cell growth in mice. Furthermore, the combination of BA-5 with a low dose of regorafenib synergistically inhibited HCC-SR cell proliferation. In conclusion, our study showed that the barbituric acid derivative BA-5 is a new candidate for HCC and sorafenib-resistant HCC therapy.


1994 ◽  
Author(s):  
S.G. Chen ◽  
X.D. Chai ◽  
Y.W. Cao ◽  
W.S. Yang ◽  
X.Y. Tang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document